'Your papers, please' must never be heard in America
French drugmaker Sanofi says its multiple sclerosis drug candidate teriflunomide did not achieve one of its goals in a late-stage clinical trial.
Three top European pharmaceutical companies announced on Tuesday disappointing news from clinical tests on drugs they had hoped would turn out to be big sellers.
